Supriya Lifescience Limited — Updates, 13-11-2025: Press Release
13-11-2025 | 02:41 pm
13-11-2025 | 02:41 pm
Supriya Lifescience delivered strong Q2 FY26 results: Revenue +20.3% YoY to Rs 199.83 Cr, PAT Rs 50.43 Cr. Capacity utilization rose to 78% in H1FY26. Anesthetic segment drove growth. Company acquired land for expansion, with Ambernath facility launching H2 FY26.
No comments yet. Be the first to comment!
